[Experiences with oral BCG therapy in chronic erythema and cutaneous tuberculosis; preliminary report].
D001500:BCG Vaccine / Q000627:therapeutic use*; D004890:Erythema / Q000628:therapy*; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D009163:Mycobacterium bovis; D014376:Tuberculosis; D014382:Tuberculosis, Cutaneous / Q000628:therapy*; D014611:Vaccination
D001500:BCG Vaccine; D007538:Isoniazid
BCG VACCINATION/therapeutic use; ERYTHEMA/therapy; ISONIAZID/therapeutic use; TUBERCULOSIS, CUTANEOUS/therapy
Tapasztalatok BCG oralis kezelésével erythematodes chronicus és bortbc-s esetekben; elozetes közlemény.